China Pharma Holdings, Inc.
CPHI
$0.65
-$0.01-1.39%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.58% | -23.30% | 32.74% | 35.84% | -9.53% |
| Total Depreciation and Amortization | 60.96% | 10.94% | -2.55% | -35.05% | -27.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12,596.52% | -48.39% | -0.24% | 2,200.00% | -119.84% |
| Change in Net Operating Assets | 28,539.57% | -117.70% | 53.97% | -81.84% | 217.64% |
| Cash from Operations | 164.14% | -181.42% | 603.63% | -119.34% | 735.74% |
| Capital Expenditure | 16.67% | -700.00% | 100.17% | -198.97% | -311.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.75% | -300.00% | 55.75% | 91.08% | -- |
| Cash from Investing | 85.71% | -310.10% | 87.78% | 70.32% | -3,066.30% |
| Total Debt Issued | 195.60% | -174.49% | -- | -- | 0.00% |
| Total Debt Repaid | -226.25% | 160.82% | -1,223.05% | -25.70% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -200.00% | -- | -- |
| Cash from Financing | 40.59% | -318.49% | 58.29% | -28.91% | -898.53% |
| Foreign Exchange rate Adjustments | -90.80% | 207.07% | -633.33% | 91.48% | -721.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.68% | -268.35% | 199.11% | -133.33% | -345.63% |